Chemtob Raphaelle A, Wierup Per, Mick Stephanie L, Gillinov A Marc
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.
J Card Surg. 2019 Oct;34(10):965-968. doi: 10.1111/jocs.14167. Epub 2019 Jul 12.
Intraoperative assessment of the repaired mitral valve (MV) by saline testing is a standard maneuver in MV repair. Despite a growing interest in application of nonresectional techniques, the utility of the saline test following repair with neochordae has not been systematically assessed. We sought to determine the accuracy of the saline test following MV repair using nonresectional techniques.
We included 25 adult patients undergoing MV repair for degenerative valve disease between November 2018 and February 2019. The surgical repair was performed using nonresectional techniques with neochordae either through a sternotomy or a robotic approach.
Twenty-five patients underwent successful MV repair, all with excellent echocardiographic results. In four patients (16%), the saline test suggested discrete areas of leaflet malcoaptation and leakage, leading to additional repair maneuvers. In 16 patients (64%), the final saline test demonstrated excellent coaptation with little or no leak. In nine patients (36%), the final saline test was inconclusive (ventricle could not be filled) or poor (diffuse leak). Post-repair intraoperative echocardiography demonstrated no or trivial mitral regurgitation in all patients, and no patient required a second pump run.
After repair with neochordae, a satisfactory saline test indicates a good repair and discrete leaks on the saline test suggest the need for further surgical maneuvers. If the surgeon has employed standard repair techniques using neochordae but the saline test is inconclusive or poor, additional repair maneuvers are generally unnecessary, as intraoperative echocardiography will usually demonstrate a good repair.
通过盐水试验对修复后的二尖瓣(MV)进行术中评估是二尖瓣修复术中的一项标准操作。尽管人们对非切除技术的应用兴趣日益浓厚,但在使用新腱索修复后进行盐水试验的效用尚未得到系统评估。我们旨在确定使用非切除技术修复二尖瓣后盐水试验的准确性。
我们纳入了2018年11月至2019年2月期间因退行性瓣膜病接受二尖瓣修复的25例成年患者。手术修复采用非切除技术并使用新腱索,通过胸骨切开术或机器人手术入路进行。
25例患者二尖瓣修复成功,所有患者的超声心动图结果均良好。4例患者(16%)的盐水试验提示瓣叶对合不良和反流的离散区域,导致进行了额外的修复操作。16例患者(64%)的最终盐水试验显示对合良好,几乎无或无反流。9例患者(36%)的最终盐水试验结果不确定(无法充盈心室)或较差(弥漫性反流)。修复后术中超声心动图显示所有患者无或仅有微量二尖瓣反流,且无一例患者需要再次进行体外循环。
使用新腱索修复后,盐水试验结果满意表明修复良好,盐水试验中离散的反流提示需要进一步的手术操作。如果外科医生采用了使用新腱索的标准修复技术,但盐水试验结果不确定或较差,通常无需进行额外的修复操作,因为术中超声心动图通常会显示修复良好。